Molecular Pathology

578 papers and 19.5k indexed citations i.

About

The 578 papers published in Molecular Pathology in the last decades have received a total of 19.5k indexed citations. Papers published in Molecular Pathology usually cover Molecular Biology (272 papers), Oncology (166 papers) and Pathology and Forensic Medicine (102 papers) specifically the topics of Cancer-related Molecular Pathways (55 papers), Genetic factors in colorectal cancer (52 papers) and Molecular Biology Techniques and Applications (49 papers). The most active scholars publishing in Molecular Pathology are Bernard Perbal, Zvi Laron, Paul N. Nelson, Barbara Valentinis, Iain Chapple, Kenzo Takada, Gerald Niedobitek, David R. Brigstock, Michael Smyth and Hilde Williams.

In The Last Decade

Fields of papers published in Molecular Pathology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Molecular Pathology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Molecular Pathology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Molecular Pathology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Molecular Pathology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025